Future impacts of applied microbiology
MIRCEN Journal of Applied Microbiology and Biotechnology, ISSN: 0265-0762, Vol: 2, Issue: 1, Page: 177-190
1986
- 9Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures9
- Readers9
Article Description
Developing countries increasingly see biotechnology as an avenue to improving the quality of life of their residents. Wonderful things are being predicted, and a capability is building to assure developing countries that they will benefit from the biotechnology revolution, and not become its victims (van Hemert et al. 1983). Outstanding in this regard, despite legal and other problems, is the establishment, by the United Nations Industrial and Development Organization (UNIDO), of twin International Centres for Genetic Engineering and Biotechnology (ICGEB). The centres are under the guidance of a panel of eminent scientific advisors that includes four Nobel Laureates. This panel is of the opinion that excellence and not nationality will be the basis for the selection of directors and senior scientific staff for the centres. One centre is planned for New Delhi, India, and its clone will be built in Trieste, Italy. Their proposed programmes are based on the assumption that three years will be required to bring the centres to full operating capacity. In the fourth year, it is expected that 31 scientists, 20 postdoctoral fellows, and 30 technicians will be working at each location. The Indian facility will focus on agricultural biotechnology and animal and human health, whereas research at Trieste will concentrate on industrial applications of biotechnology. At both locations, programmes will be relevant to problems of developing nations, they will not duplicate programmes at other institutions, and to the greatest extent possible, they will be result-orientated. A biophysicist, Dr Burke Zimmerman, has been appointed Acting Director of the centre's projects. He has been a consultant to biotechnology firms and to the United States Congress as well as a special assistant to the Director of the National Institutes of Health. He is experienced in policy-making on a broad spectrum of scientific and environmental issues, and in his recent book Biofuture: Confronting the Genetic Era, Dr Zimmerman (1984) wrote, "The next decade will witness many efforts to extend biotechnology to all corners of the world. Idealism, however, must be coupled with a keen sense of the real problems which now confront developing countries, whether economic, educational, political or ideological. Some countries are torn by war at present; many others are in the midst of severe economic crisis. It would be too much to expect these endeavours to proceed smoothly and logically, governed by vision. Instead, biotechnology is likely to come slowly to the areas of the world which need it most, through trial, error, and muddling along, through the sustained efforts of dedicated men and women, but, in time, changing the way the world lives." © 1986 Oxford University Press.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=34250131414&origin=inward; http://dx.doi.org/10.1007/bf00937192; http://link.springer.com/10.1007/BF00937192; http://link.springer.com/content/pdf/10.1007/BF00937192; http://link.springer.com/content/pdf/10.1007/BF00937192.pdf; http://link.springer.com/article/10.1007/BF00937192/fulltext.html; http://www.springerlink.com/index/pdf/10.1007/BF00937192; https://dx.doi.org/10.1007/bf00937192; https://link.springer.com/article/10.1007/BF00937192; http://www.springerlink.com/index/10.1007/BF00937192
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know